Translation of "response time commitment" to Slovene language:
Examples (External sources, not reviewed)
| 3.2.2 Availability and time commitment | 3.2.2 Razpoložljivost in čas |
| A time commitment of x hours per month. | Temu bi posvetili določeno število ur na mesec. |
| Days (months) Time to response | (4, 1) |
| Time to response CR PR (days) a | CR PR (dnevi) a |
| Time to complete response in both classifications of response ranged from 2.9 to 11.7 weeks. | Po obeh definicijah odziva je bil popolni odziv dosežen po 2, 9 do 11, 7 tednih. |
| Additional response after this time is unlikely (see 5.1). | Dodatni odziv po preteku tega obdobja ni verjeten (glejte poglavje 5. 1). |
| 90 n ( ) Time to first response in CR PR | 90 n ( ) Čas do prvega odziva pri CR PR |
| For time to response and duration of response no difference could be recorded between the arms. | Med skupinama ni bilo razlik v času do odgovora na zdravljenje in trajanju odgovora. |
| Number (proportion) with 1 hour ON time response Secondary Outcome | število (delež) odgovorov z enournim vključitvenim (ON time) obdobjem Sekundarni izidi |
| Overall Response Rate ( ) (95 Confidence Interval) Complete Response Partial Response Median Duration of Response (months) (95 Confidence Interval) Median time to Response (months) (95 Confidence Interval) Progression Free Survival (months) (95 Confidence Interval) Survival (months) | Celokupni delež odziva ( ) (95 interval zaupanja) Popoln odziv Delen odziv Mediana trajanja odziva (meseci) (95 interval zaupanja) |
| Major cytogenetic response, haematological response, molecular response (evaluation of minimal residual disease), time to accelerated phase or blast crisis and survival are main secondary endpoints. | Pomemben citogenetski odziv, hematološki odziv, molekularni odziv (ovrednotenje minimalne rezidualne bolezni), čas do pospešene faze ali blastne krize in preživetje so poglavitni sekundarni cilji opazovanja. |
| 37 , p 0.01) and shortened time to response (12 weeks vs. | Docetaksel ni vplival na celotni čas preživetja (docetaksel 15 mesecev, doksorubicin 14 mesecev, p 0, 38) niti na čas do napredovanja (docetaksel 27 tednov, doksorubicin 23 tednov, p 0, 54), je pa zvečal delež odziva (52 v prim. s 37 , p 0, 01) in skrajšal čas do odziva (12 tednov v prim. s 23 tedni, p 0, 007). |
| Duration of response Disease free survival (DFS) Time to new treatment | trajanje odgovora preživetje brez bolezni čas do novega zdravljenja |
| Median time to loss of response through week 54 Week 30 | Mediana vrednost časa do izginotja odziva v obdobju do 54. tedna 30. teden |
| Median time to loss of response through week 54 Week 54 | Mediana vrednost časa do izginotja odziva v obdobju do 54. tedna 54. teden |
| CI confidence interval, FOLFIRI irinotecan plus infusional 5 FU FA, ORR objective response rate (patients with complete response or partial response), PFS progression free survival time | IZ interval zaupanja FOLFIRI irinotekan in infundirani 5 FU FA ORR (objective response rate) objektivna stopnja odgovora (bolniki s popolnim odgovorom ali delnim odgovorom) PFS (progression free survival time) čas preživetja brez napredovanja bolezni |
| CI confidence interval, FOLFOX oxaliplatin plus infusional 5 FU FA, ORR objective response rate (patients with complete response or partial response), PFS progression free survival time | IZ interval zaupanja FOLFOX oksaliplatin in infundirani 5 FU FA ORR (objective response rate) objektivna stopnja odgovora (bolniki s popolnim odgovorom ali delnim odgovorom) PFS (progression free survival time) čas preživetja brez napredovanja bolezni |
| to contribute to the design of consensusbased standards , with a clear commitment for implementation on time | sodeluje pri oblikovanju soglasno določenih standardov z jasno zavezo za njihovo pravočasno uvedbo |
| The median time to response in clinical trials was 7.6 11.6 weeks. | Srednji odzivni čas je v kliničnih raziskavah znašal od 7, 6 do 11, 6 tednov. |
| The projected time for lesions that were in partial response (PR) to later attain clinical complete response (CCR) was 168 days. | Napovedani čas za lezije, ki so naprej pokazale delni odziv (PR) in dosegle kasnejši celotni klinični odziv (CCR), je bil 168 dni. |
| The secondary objectives included complete response (CR) and overall response (CR or partial response) rates using the 1996 NCIWG criteria, the duration of response, time to alternative treatment and safety of the two treatment arms. | Ocenjena verjetnost |
| Objective response rate and progression free survival time were significantly improved with cetuximab. | Objektivna stopnja odgovora in čas preživetja brez napredovanja bolezni sta se pri jemanju cetuksimaba bistveno izboljšala. |
| Imputations according to the TLOVR algorithm (TLOVR Time to Loss of Virologic Response) | Pripisane vrednosti po algoritmu TLOVR (TLOVR čas do izginotja virološkega odziva) |
| To compare the average time to response following treatment with anagrelide or hydroxyurea. | Primerjava povprečnega časa, ki preteče do odgovora na zdravljenje z anagrelidom ali hidroksisečnino. |
| a Indicate the calendar for the real time response simulations of emergency situations | a Navedite časovni razpored simulacij odziva na izredne razmere v realnem času. |
| CI confidence interval, CTX platinum based chemotherapy, ORR objective response rate, OS overall survival time, PFS progression free survival time | IZ interval zaupanja KOP kemoterapija na osnovi platine ORR (objective response rate) objektivna stopnja odgovora OS (overall survival) skupni čas preživetja PFS (progression free survival time) čas preživetja brez napredovanja bolezni |
| to contribute to the design of consensusbased selection of standards with a clear commitment for implementation on time | prispeva k oblikovanju soglasno določenega nabora standardov in se jasno zaveže , da jih bo pravočasno začela izvajati |
| 5.5 At one time, the Commission was minded to propose a unilateral commitment to cut emissions by 30 . | 5.5 Komisija je prvotno menila, da lahko predlaga enostransko zavezo zmanjšanja emisij za 30 , saj so se zaradi gospodarske krize, s katero se je soočala Evropa, emisije zmanjšale. |
| Entire life commitment meaning 24 7 365 work commitment. | Doživljenska pripadnost pomeni 24 7 365 delovno obveznost. |
| The clinical response rate was 18.5 , median time to progression was 2.8 months (CI | Klinični delež odgovorov je bil 18, 5 , mediana časa do napredovanja bolezni je bila 2, 8 meseca (CI |
| The MCyR rate was 27 with a median time to response of 2.0 months. | Delež pomembnih citogenetičnih odzivov je bil 27 z mediano časa do odziva 2, 0 meseca. |
| Secondary efficacy endpoints included time to disease progression (TTP) and duration of response (DR). | Končni točki sekundarnih učinkov sta bili čas do napredovanja bolezni (TTP) in trajanje odgovora (DR duration of response). |
| Agricultural production is seasonal, with a time lag between market signals and producers' response. | Kmetijska proizvodnja je sezonska, s časovnim zamikom med tržnimi signali in odzivom proizvajalcev. |
| to contribute to the design of a consensusbased selection of standards , with a clear commitment for implementation on time | prispevati k oblikovanju soglasno določenega niza standardov , z jasno zavezo k njihovi pravočasni implementaciji |
| The median time to onset of response in the infliximab treated group was 2 weeks. | Mediani čas do nastopa odziva v skupini, zdravljeni z infliksimabom, je bil 2 tedna. |
Related searches: Response Time Commitment - Stimulus And Response Response - Real-time Response Time - Time Commitment - Long Time Commitment - Full Time Commitment - Working Time Commitment - Extensive Time Commitment - Commitment In Time - Commitment Of Delivery Time -